MRNA Buybacks
8 quarter-specific issuer repurchase-cash observations normalized from SEC filings, newest first. A filed zero remains visible; a missing filing fact is never converted into zero. This page shows rows 1–8; provenance stays internal.
| Issuer profile | Period end | Type | Reported cash |
|---|---|---|---|
| Moderna, Inc. | 2024-12-31 | Reported repurchase cash | $0.00 |
| Moderna, Inc. | 2024-03-31 | Reported repurchase cash | $0.00 |
| Moderna, Inc. | 2023-12-31 | Reported repurchase cash | $0.00 |
| Moderna, Inc. | 2023-03-31 | Reported repurchase cash | $526M |
| Moderna, Inc. | 2022-12-31 | Reported repurchase cash | $402M |
| Moderna, Inc. | 2022-03-31 | Reported repurchase cash | $623M |
| Moderna, Inc. | 2021-12-31 | Reported repurchase cash | $857M |
| Moderna, Inc. | 2021-03-31 | Reported repurchase cash | $0.00 |